Disability progression in relapsing MS tends to follow one of four distinct patterns, according to a new study.
A predictive tool considering disease duration, age at disease onset, age, and Expanded Disability Status Scale score estimated patients’ risk of transition to secondary progressive multiple sclerosis ...
Tolebrutinib failed to meet the primary endpoint in the phase 3 PERSEUS study involving patients with primary progressive multiple sclerosis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback